Richard Lee

Richard obtained his Ph.D. from McMaster University, Canada, where he focused on strategies for metabolite identification and metabolomics studies.  From McMaster, he moved on as a Scientist, as part of the Drug Development group, at the Centre of Probe Development and Commercialization, focusing on radio-pharmaceutical imaging agents and radio-therapeutics for oncology.  He has been with ACD/Labs for the past 9 years and during this time, has been responsible for inception and development of MetaSense—software to support metabolite identification.  For the last 5 years he has been ushering new technology development, laying the foundations for the next generation of ACD/Labs software, as a member of the Innovation and Informatics Strategy team.